No results for ‘’
Aarti Pharmalabs Ltd
NSE: AARTIPHARM BSE: 543748
₹691.80
(5.06%)
Sun, 21 Jun 2026, 08:59 pm
Market Cap (in Cr)6266.26
PE Ratio33.63
Dividend0.61
Aarti Pharmalabs Ltd About
Aarti Pharmalabs The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates and Xanthine Derivatives in India.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
2019
Headquarters
CEO
Rashesh C Gogri
Employees
Contact
Website
https://www.aartipharmalabs.com
co.apl@aartipharmalabs.com ; investorrelations@aar
Phone
91-22-6797 6666
Location
Plot No 22/C/1 & 22/C/2, 1st Phase GIDC Vapi, Valsad, Gujarat, 396195